Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with

Manuel Baños1, Monica G Arellano-Mendoza, Hilda Vargas-Robles

  • 1Department of Molecular Biomedicine, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional México City, C.P. 07360, Mexico.

Insights

Cardiovascular risk factors and the ACE I/D DD genotype increase Angiotensin II AT1 receptor expression in the aorta. This heightened expression is linked to coronary artery disease development.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Genetics

Background:

  • Angiotensin II (Ang) receptor density is influenced by various factors and pathological conditions.
  • The role of cardiovascular risk factors in regulating Angiotensin II receptor expression is not fully understood.

Purpose of the Study:

  • To investigate the association between cardiovascular risk factors and Angiotensin II AT1 and AT2 receptor expression in human aortic arteries.
  • To explore the link between ACE I/D genotype and Angiotensin II receptor expression.

Main Methods:

  • Ex-vivo study using human aortic postsurgical specimens from 31 Mexican patients with coronary artery disease.
  • Immunostaining to evaluate Angiotensin II receptor expression.
  • Polymerase chain reaction to determine angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphisms.

Main Results:

  • Both AT1 and AT2 receptor expression were elevated in aortic segments of cardiovascular patients compared to controls.
  • Patients with the DD genotype showed increased AT1 and AT2 receptor expression.
  • Increased AT1 receptor expression correlated with the number of cardiovascular risk factors and decreased with drug combinations.
  • No such correlations were observed for AT2 receptor expression.

Conclusions:

  • Increased AT1 receptor expression is associated with the DD genotype and the presence of cardiovascular risk factors.
  • Elevated AT1 receptor expression may contribute to the development of coronary occlusive disease.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...